From the Wires
Mergers and Acquisitions Remain Key in Big Pharma's 2013 Playbook, an Industrial Info News Alert
By: Marketwired .
Jan. 28, 2013 06:15 AM
SUGAR LAND, TX -- (Marketwire) -- 01/28/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- In the absence of the avalanche of mega-industry mergers and acquisitions (M&A) seen in previous years, many pundits have proclaimed the end of that particular business tool as an essential component in Big Pharma's playbook. While the numbers in 2012 were lower than in years past in both quantity and value, it is clear that M&A plans remain a key factor for the industry. With 2013 barely under way, there are many rumors of new deals ahead.
Other companies featured: Pfizer Incorporated (NYSE:PFE), Merck (NYSE:MRK), Bristol-Myers Squibb (NYSE:BMY), GlaxoSmithKline (NYSE:GSK), Watson Pharmaceuticals Incorporated (NYSE:WPI), Allergan Incorporated (NYSE:AGN), MAP Pharmaceuticals (NASDAQ:MAPP)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showAbstract.jsp?newsitemID=232970&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.
Latest Cloud Developer Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week